Summary
UnitedHealth Group's 2017 10-K filing reveals a strong financial performance driven by robust growth across its UnitedHealthcare and Optum segments. The company demonstrated significant revenue increases, bolstered by expansion in Medicare Advantage and Medicaid, alongside consistent growth in its health services arm, Optum. Diluted earnings per share saw a substantial jump, partly attributed to the Tax Cuts and Jobs Act, which positively impacted the company's tax rate. Strategically, UnitedHealth Group continues to leverage its dual platform approach, with UnitedHealthcare offering diversified health benefits and Optum providing a suite of health services. The company's commitment to innovation is evident in its increasing engagement with value-based care models and its continuous investment in technology and data analytics. Despite facing pressures in Medicare Advantage funding and the return of the Health Insurance Industry Tax, UnitedHealth Group maintains a positive outlook, focusing on operational efficiency and member-focused care to drive future growth and profitability.
Financial Highlights
56 data points| Revenue | $201.16B |
| Cost of Revenue | $24.11B |
| Gross Profit | $177.05B |
| SG&A Expenses | $29.56B |
| Operating Expenses | $185.95B |
| Operating Income | $15.21B |
| Interest Expense | $1.19B |
| Net Income | $10.56B |
| EPS (Basic) | $10.95 |
| EPS (Diluted) | $10.72 |
| Shares Outstanding (Basic) | 964.00M |
| Shares Outstanding (Diluted) | 985.00M |
Key Highlights
- 1Consolidated revenues increased by 9% to $201.16 billion, driven by 10% growth in UnitedHealthcare and 9% growth in Optum.
- 2Diluted earnings per share (EPS) rose significantly by 48% to $10.72, with $1.22 of this increase attributable to the Tax Cuts and Jobs Act.
- 3UnitedHealthcare segment experienced strong membership growth, particularly in Medicare Advantage (up 22%) and Medicaid (up 14%).
- 4Optum segment reported solid revenue and earnings growth across all its sub-segments: OptumHealth, OptumInsight, and OptumRx.
- 5Cash flows from operations were robust, increasing by 39% to $13.6 billion, indicating strong operational cash generation.
- 6The company returned significant capital to shareholders through dividends ($2.77 billion) and share repurchases ($1.5 billion) in 2017.